Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest Claudication Stories

2013-11-18 20:57:58

Joseph Poole, M.D., Ph.D., of the Emory University School of Medicine, Atlanta, and colleagues studied whether therapy with granulocyte-macrophage colony stimulating factor (GM-CSF), an agent that functions as a white blood cell growth factor, would improve walking performance in patients with symptomatic peripheral artery disease (a form of vascular disease in which there is partial or total blockage of an artery, usually one leading to a leg or arm). "Peripheral artery disease (PAD)...

2013-07-03 11:02:00

In a trial that included nearly 200 participants with peripheral artery disease (PAD), a home-based exercise intervention with a group-mediated cognitive behavioral intervention component improved walking performance and physical activity in patients with PAD, according to a study in the July 3 issue of JAMA. "Few medical therapies improve the functional impairment associated with lower extremity peripheral artery disease. Supervised treadmill exercise increases maximal treadmill walking...

2013-03-04 16:25:43

ALISO VIEJO, Calif., March 4, 2013 /PRNewswire-USNewswire/ -- The mild® procedure, a minimally-invasive outpatient procedure designed to provide relief to patients suffering with the common back condition lumbar spinal stenosis (LSS), demonstrates durable pain relief and improvement in mobility over a two year period according to new study data. The study monitored 45 patients at 11 sites during a two year period and is currently the longest multi-center study in publication on the mild...

2012-10-17 11:24:18

12,000 Patients Treated; Cleveland Clinic Study Documents Effectiveness ALISO VIEJO, Calif., Oct. 17, 2012 /PRNewswire-USNewswire/ -- The mild® procedure, an innovative outpatient back-pain treatment, has passed a major milestone - more than 12,000 patients have received the treatment across the U.S. In addition, a growing number of clinical studies, including a recent trial published by the prestigious Cleveland Clinic, show that mild helps patients stand longer and walk farther...

2011-11-17 03:06:29

Findings of CLEVER trial for peripheral artery disease presented at American Heart Association annual meeting Supervised exercise was shown to be more effective than stenting or medication for improved walking ability in patients with peripheral artery disease. The findings from a national study were reported today at the 2011 American Heart Association Scientific Sessions meeting. Rhode Island Hospital is one of hospitals participating in the national CLEVER study. Peripheral artery...

2011-09-29 10:33:00

HUDSON, N.H., Sept. 29, 2011 /PRNewswire/ -- Atrium Medical Corporation today announced the publication of the COBEST Trial by the Journal of Vascular Surgery. COBEST (Covered Versus Balloon Expandable Stent Trial) was an independent, landmark, prospective, multi center, randomized, controlled clinical trial that has demonstrated that Atrium's proprietary balloon expandable covered stent technology is superior to traditional bare metal stents for the treatment of aorto-iliac disease. The...

2011-09-06 20:36:40

Legs For Life® screening available during National PAD Awareness Month; exercise, intervention may help individuals 'go the distance,' note researchers in Journal of Vascular and Interventional Radiology Peripheral arterial disease, or PAD, is a common condition affecting 12-20 percent of Americans age 65 and older that may be a signal of future heart attack and stroke–and many with the disease may be unaware they have it, says the Society of Interventional Radiology. For more...

2010-11-02 06:00:00

HUDSON, N.H., Nov. 2, 2010 /PRNewswire/ -- Atrium Medical Corporation is pleased to announce that the final patient was recently enrolled in the iCAST(TM) Atrium Registry Ultrasound Study (iCARUS). This study is a prospective, multi-center clinical trial studying the safety and efficacy of the Atrium iCAST(TM) Balloon Expandable Covered Stent in patients with occlusive disease of the iliac artery. Atrium's proprietary "balloon expandable" covered stent clinical study is approved by the...

2010-10-12 18:50:30

Even after initial procedures to clear blockages in leg arteries, hospitalizations and associated costs in patients with peripheral artery disease increase as the condition progresses, according to research reported in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal. "We are dealing with clinically and economically severe consequences of PAD, a disease which is truly preventable," said Elizabeth Mahoney, Sc.D., the study's lead author. "Our prior...

2010-10-12 15:00:00

Study Highlights: - Peripheral artery disease (PAD) is a progressive and costly disease, but remains under-diagnosed and under treated. - While current PAD treatments are effective at clearing artery blockages in the lower leg, high recurrence rates and the subsequent need for repeat procedures are costly. - More widespread use of diagnostic tests and preventive strategies early in the disease course may help slow PAD's progression and minimize the risk of poor outcomes. DALLAS, Oct. 12...